Equities research analysts predict that Liminal BioSciences Inc. (NASDAQ:LMNL – Get Rating) will post earnings per share of ($0.16) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Liminal BioSciences’ earnings. Liminal BioSciences posted earnings of ($0.52) per share in the same quarter last year, which indicates a […]